Antibody responses to BNT162b2 mRNA vaccine: infection-naïve individuals with abdominal obesity warrant attention.

Alexis Elias MalavazosSara BasilicoGianluca IacobellisValentina MilaniRosanna CardaniFederico BoniardiCarola DubiniIlaria PrandoniGloria CapitanioLaura Valentina RennaSara BoveriRoberta RigoliniMatteo CarraraGiovanni SpuriaTeresa CupponeAurelia D'acquistoLuca CarpinelliMarta SacchiLelio MorriconeFrancesco SecchiElena CostaLorenzo MenicantiEnzo NisoliMichele CarrubaFederico AmbrogiMassimiliano Marco Corsi Romanelli

Published in: Obesity (Silver Spring, Md.) (2021)

The waning antibody levels in individuals with AO may further support recent recommendations to offer booster vaccines to adults with high-risk medical conditions including obesity and particularly to those with more prevalent abdominal obesity phenotype.

Keyphrases

insulin resistance
metabolic syndrome
weight loss
high fat diet induced
type diabetes
weight gain
healthcare
working memory
adipose tissue
skeletal muscle
body mass index
clinical practice